Published in Medical Imaging Week, December 30th, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at University of Cincinnati, U.S.
Report 1: A research team led by University of Cincinnati (UC) scientists has received $1 million from the National Cancer Institute to develop a new topical treatment that would not only increase skin pigmentation to block harmful ultraviolet (UV) rays, but also repair damage that can lead to skin cancer.
The researchers will work with a chemically modified hormone called alpha-melanocyte stimulating hormone (alpha-MSH). Known...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Week